fulvestrant
- Product NDC
- 25021-462
- 11-digit product format
- 250210462
- Labeler code
- 25021
- Product ID
- 25021-462_57653230-ed2e-48b8-b53b-f1ee120626c9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fulvestrant
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA205871
- Marketing category
- ANDA
- Marketing start
- 2019-08-01
- Marketing end
- 0000-00-00
- Substance
- FULVESTRANT
- Active strength
- 50 mg/mL
- Pharmacologic classes
- Estrogen Receptor Antagonist [EPC],Estrogen Receptor Antagonists [MoA],Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-462-74 | 25021046274 | 2 SYRINGE in 1 CARTON (25021-462-74) > 5 mL in 1 SYRINGE | 2 syringe | 2019-08-01 | 0000-00-00 | No | No | Current |